Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SmithKline severances

Executive Summary

Firm's proxy statement for April 26 annual meeting details resignation packages for three of the recently departed senior execs: President George Ebright ( $ 1.16 mil. plus approximately $ 250,000 annual retirement benefits); SK&F R&D President Stanley Crooke ( $ 620,000, a $ 310,000 three-year interest-free loan, $ 25,000 per year for two years consulting, and $ 250,000 each year for four years "to support Dr. Crooke's ongoing research"); SK&F Labs President James Cavanaugh ( $ 540,000). Part of the cost of the severance packages was defrayed by a cut in the bonus to SmithKline Chairman Henry Wendt. The chairman received a $ 750,000 bonus for 1987 and no bonus in 1988.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015359

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel